Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk assessment model based on nucleotide metabolism-related genes highlights SLC27A2 as a potential therapeutic target in breast cancer

16 May 2024

Abstract excerpt

PURPOSE: Breast cancer (BC) is the most prevalent malignant tumor worldwide among women, with the highest incidence rate. The mechanisms underlying nucleotide metabolism on biological functions in BC remain incompletely elucidated. MATERIALS AND METHODS: We harnessed differentially expressed nucleotide metabolism-related genes from The Cancer Genome Atlas-BRCA, constructing a prognostic risk model through...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38753091
DOI: 10.1007/s00432-024-05754-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk assessment model based on nucleotide metabolism-related genes highlights SLC27A2 as a potential therapeutic target in breast cancerPMID 38753091Read ↗

Purine and pyrimidine metabolism regulatory gene signature predicts prognosis and immunotherapy efficiency in breast cancerSemantic proximity Read ↗

The metabolism-related lncRNA signature predicts the prognosis of breast cancer patientsSemantic proximity Read ↗

Construction of a prognostic model of purine metabolism-related genes for breast cancer and validation of key gene PAICSSemantic proximity Read ↗

Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancerSemantic proximity Read ↗

Single-cell sequencing and transcriptome analysis identified a comprehensive risk score model based on immune-related metabolic genes for improving the prediction of sensitivity in breast cancer immunotherapySemantic proximity Read ↗

Integrated bulk and single-cell transcriptomic analysis reveals a tryptophan metabolism-driven prognostic signature and therapeutic landscape in triple- negative breast cancerSemantic proximity Read ↗

Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancerSemantic proximity Read ↗

Integrated bulk and single-cell transcriptomic analysis unveiled a novel cuproptosis-related lipid metabolism gene molecular pattern and a risk index for predicting prognosis and antitumor drug sensitivity in breast cancerSemantic proximity Read ↗

Risk model of nucleotide metabolism and immunity signature genes in predicting of hepatocellular carcinoma prognosis and immune microenvironmentSemantic proximity Read ↗

Correlation between metabolic characteristics and breast cancer subtypes and prognosisSemantic proximity Read ↗

Construction of a Prognostic Model for Lung Adenocarcinoma Based on Nucleotide Metabolism-Related Genes and Bioinformatics AnalysisSemantic proximity Read ↗

A pyrimidine metabolism-related gene signature for prognosis prediction and immune microenvironment description of breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.